|
|
Title | Creator | Relation Is Part Of |
1 |
|
Should I Have Teprotumumab or Surgery? | Alison V. Crum, MD | NANOS Annual Meeting 2023: Ophthalmic Surgery in the Neuro-Ophthalmic Patient: https://novel.utah.edu/collection/NAM/toc/ |
2 |
|
Should I Have Teprotumumab or Surgery? | Alison V. Crum, MD | NANOS Annual Meeting 2023: Ophthalmic Surgery in the Neuro-Ophthalmic Patient |
3 |
|
Thyroid Eye Disease - Pilot Study | Frisard; Nicholas E; Rowland, Anne P; Acierno, Marie D; Cockerham, Kimberly P; Hariri, Adham Al | NANOS 2013: Poster Presentations |
4 |
|
Ocular Motility in Thyroid Eye Disease Evaluation and Surgery | Steven E. Feldon, MD, University of Rochester Medical Center | NANOS 2010: IV Thyroid Eye Disease Update |
5 |
|
Ocular Motility in Thyroid Eye Disease Evaluation and Surgery | Steven E. Feldon, MD, University of Rochester Medical Center | NANOS 2010: IV Thyroid Eye Disease Update |
6 |
|
Efficacy of Restasis(R) (0.05% Cyclosporine A) Ophthalmic Emulsion in Patients with Thyroid Eye Disease (TED) | Crow, Lauren; Cockerham, Kimberly; Li, Jing | NANOS 2007: Poster Presentations |
7 |
|
Thyroid Eye Disease in Young Patients Compared with Older | Huna-Baron, Ruth; Katz, Gaby; Leiba, Hana; Hadas, Biatrix; Simon, Guy J Ben | NANOS 2010: Poster Presentations |
8 |
|
Development of Increased Vertical Fusional Amplitudes in Patients with Thyroid Eye Disease | Breker, Dane; Cornblath, Wayne | NANOS 2012: Poster Presentations |
9 |
|
Quantifying Success of Radiation Therapy for Thyroid Optic Neuropathy | Zak, Rochelle S; Winterkorn, J; Rush, S | NANOS 1996: Scientific Platform Presentations (Session 1) |
10 |
|
Orbital Fibroblasts From Thyroid Eye Disease Patients Differ In Proliferative And Adipogenic Responses Depending On Disease Sub-type | Ajay E. Kuriyan, MD, University of Rochester Medical Center; Collynn F. Woeller, MD, University of Rochester Medical Center; Charles W. O'Loughlin, MD, University of Rochester Eye Institute; Richard P. Phipps, MD, University of Rochester Eye Institute; Steven E. Feldon, MD, University of Rochester M... | NANOS 2014: Scientific Platform Presentations (Session 2) |
11 |
|
Orbital Fibroblasts From Thyroid Eye Disease Patients Differ In Proliferative And Adipogenic Responses Depending On Disease Sub-type | Ajay E. Kuriyan, MD, University of Rochester Medical Center; Collynn F. Woeller, MD, University of Rochester Medical Center; Charles W. O'Loughlin, MD, University of Rochester Eye Institute; Richard P. Phipps, MD, University of Rochester Eye Institute; Steven E. Feldon, MD, University of Rochester M... | NANOS 2014: Scientific Platform Presentations (Session 2) |
12 |
|
Adult with Acquired Oblique Diplopia: Do I Image? Do I Operate? (PDF) | Hilda Capó, MD | NANOS Annual Meeting 2020: Strabismus: Image? Operate? |
13 |
|
Orbital Ultrasound as the Primary Imaging Modality in Patients with Ocular Misalignment and Suspected Thyroid Eye Disease | Volpe, Nicholas J; Sbarbaro, james; Gendron, EK; Liu, Grant; Galetta, Steven; Balcer, Laura | NANOS 2003: Scientific Platforms Presentations II |
14 |
|
Objective Markers for Thyroid Eye Disease (TED) Activity, Severity 387 and Progression | Kimberly Cockerham, MD, FACS | NANOS 2010: IV Thyroid Eye Disease Update |
15 |
|
Objective Markers for Thyroid Eye Disease (TED) Activity, Severity 387 and Progression | Kimberly Cockerham, MD, FACS | NANOS 2010: IV Thyroid Eye Disease Update |
16 |
|
Eye Movement Fatigibility in Myasthenia Gravis Observed by Video-oculography | Ju-Hee Chae, Hyun-June Shin, Sun-Young Oh | NAM 2019: Poster Session II: Scientific Advancements in Neuro-Ophthalmology |
17 |
|
Checkpoint inhibitor associated orbital inflammation masquerading as ocular myasthenia gravis and thyroid eye disease | Marisa Tieger, Eric Gaier, Sashank Prasad, Michael Yoon | NAM 2019: Poster Session I: Clinical Highlights in Neuro-Ophthalmology |
18 |
|
Sustainability of Teprotumumab Efficacy in Thyroid Eye Disease | Prem S. Subramanian, Saba Sile, Robert Holt, Raymond Douglas | NANOS Annual Meeting 2022: Scientific Platform III |
19 |
|
Eyetracking in Pediatric Multiple Sclerosis | Andrew Yousef, Michael Deveruex, Pierre-Antoine Gourraud, Soren Jonzzon, Leena Suleiman, Janet Chong, Emmanuelle Waubant, Ari Green, Jennifer Graves | NANOS 2018: Poster Presentations |
20 |
|
Compressive Optic Neuropathy? - A Case of Thyroid-associated Optic Neuropathy without Crowding Orbital Apex | Ko-Jo Lin | NANOS 2018: Poster Presentations |
21 |
|
All Signs Point to Giant Cell Arteritis | Dmitry Balian, Brooke Johnson, Peter MacIntosh | NANOS Annual Meeting 2020: Poster Session I: Clinical Highlights |
22 |
|
Immunology of Thyroid Eye Disease | Feldon, Steven E; Phipps, Richard | NANOS 2007: Immunological Diseases in Neuro-Ophthalmology |
23 |
|
Teprotumumab Efficacy in Retreatment and Longer-Term Thyroid Eye Disease: OPTIC-X Study Results | Raymond Douglas, Saba Sile, Terry Smith, George Kahaly | NANOS Annual Meeting 2021: Scientific Platform Session I |
24 |
|
Extraocular Muscle Enlargement in Thyroid Eye Disease Using Volumetric Analysis | Kristen Park; Joyce Wen; Joy Li; Shirley Li; Johnny Lee; Kimberly Gokoffski; Alexander Lerner; Vishal Patel; Sandy Zhang-Nunes; Jessica Chang | NANOS Annual Meeting 2023: Poster Session II: Ocular-Imaging |
25 |
|
Case Report: Occult GCA Presented with Episodes of Transient Visual Loss and Subsequently Developed CRAO | Pitchaya Amornvararak | NANOS Annual Meeting 2020: Poster Session I: Clinical Highlights |